EcoDrugPlus

Adenosine Deaminase

Ensembl ID : ENSAOCG00000013162
Gene Symbol: ADA
3 Cross references
219 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSAOCG00000016694
Gene Symbol: LOC111583423
3 Cross references
201 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSAOCG00000023107
Gene Symbol: LOC111573852
2 Cross references
128 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSAOCG00000023435
Gene Symbol: LOC111575919
2 Cross references
232 Possible Orthologues:

Adenosine Receptor A3-Like

Ensembl ID : ENSAOCG00000005386
Gene Symbol: LOC111580062
2 Cross references
121 Possible Orthologues:

Adhesion Regulating Molecule 1

Ensembl ID : ENSAOCG00000022584
Gene Symbol: ADRM1
3 Cross references
197 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSAOCG00000011350
Gene Symbol: ADRA1B
3 Cross references
192 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSAOCG00000006521
Gene Symbol: ADRA1D
3 Cross references
195 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSAOCG00000011626
Gene Symbol: ADRA2A
3 Cross references
108 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSAOCG00000003934
Gene Symbol: ADRA2C
3 Cross references
156 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSAOCG00000003560
Gene Symbol: ADRB1
1 Cross references
163 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSAOCG00000021933
Gene Symbol: ADRB2
3 Cross references
168 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).